SHANGHAI KINLITA CHEMICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.88 CNY | -1.84% |
|
+0.68% | -39.88% |
| Apr. 26 | Shanghai Kinlita Chemical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 18 | KNT Holdings Renews Supply Deal with Veromia | MT |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,117 | 2,766 | 7,999 | 7,133 | 2,544 | 4,650 |
| Enterprise Value (EV) 1 | 1,958 | 2,554 | 7,709 | 7,094 | 2,514 | 4,573 |
| P/E ratio | 188 x | 91.9 x | 86.1 x | -63.4 x | -23.6 x | 326 x |
| Yield | - | 0.17% | 0.12% | - | - | - |
| Capitalization / Revenue | 2.62 x | 3.4 x | 9.04 x | 8.31 x | 3.93 x | 6.33 x |
| EV / Revenue | 2.42 x | 3.14 x | 8.71 x | 8.27 x | 3.89 x | 6.22 x |
| EV / EBITDA | 60.5 x | 45.6 x | 84.6 x | -64.7 x | -26.6 x | 80.9 x |
| EV / FCF | -42.2 x | 81.5 x | 1,104 x | -34.7 x | 18.6 x | -177 x |
| FCF Yield | -2.37% | 1.23% | 0.09% | -2.88% | 5.37% | -0.56% |
| Price to Book | 2.4 x | 3.04 x | 7.92 x | 7.83 x | 3.3 x | 5.24 x |
| Nbr of stocks (in thousands) | 470,340 | 470,340 | 489,205 | 489,205 | 489,205 | 475,430 |
| Reference price 2 | 4.500 | 5.880 | 16.35 | 14.58 | 5.200 | 9.780 |
| Announcement Date | 4/24/19 | 4/26/20 | 4/28/21 | 4/29/22 | 4/26/23 | 4/26/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 808.7 | 813.5 | 885 | 858 | 646.9 | 734.7 |
| EBITDA 1 | 32.35 | 55.98 | 91.13 | -109.7 | -94.53 | 56.5 |
| EBIT 1 | 3.276 | 27.21 | 61.77 | -142.5 | -128.3 | 23.07 |
| Operating Margin | 0.41% | 3.35% | 6.98% | -16.61% | -19.83% | 3.14% |
| Earnings before Tax (EBT) 1 | 11.19 | 32.46 | 104.5 | -137.5 | -125.9 | 18.35 |
| Net income 1 | 11.07 | 30.08 | 91.29 | -110.7 | -106.1 | 14.33 |
| Net margin | 1.37% | 3.7% | 10.32% | -12.9% | -16.4% | 1.95% |
| EPS 2 | 0.0240 | 0.0640 | 0.1900 | -0.2300 | -0.2200 | 0.0300 |
| Free Cash Flow 1 | -46.41 | 31.34 | 6.982 | -204.7 | 135 | -25.81 |
| FCF margin | -5.74% | 3.85% | 0.79% | -23.85% | 20.87% | -3.51% |
| FCF Conversion (EBITDA) | - | 55.99% | 7.66% | - | - | - |
| FCF Conversion (Net income) | - | 104.2% | 7.65% | - | - | - |
| Dividend per Share | - | 0.0100 | 0.0200 | - | - | - |
| Announcement Date | 4/24/19 | 4/26/20 | 4/28/21 | 4/29/22 | 4/26/23 | 4/26/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 159 | 212 | 289 | 38.6 | 29.8 | 76.8 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -46.4 | 31.3 | 6.98 | -205 | 135 | -25.8 |
| ROE (net income / shareholders' equity) | 1.03% | 3.24% | 9.16% | -12.2% | -12.5% | 1.84% |
| ROA (Net income/ Total Assets) | 0.17% | 1.46% | 2.96% | -6.52% | -6.62% | 1.2% |
| Assets 1 | 6,387 | 2,057 | 3,081 | 1,696 | 1,602 | 1,194 |
| Book Value Per Share 2 | 1.870 | 1.930 | 2.060 | 1.860 | 1.580 | 1.860 |
| Cash Flow per Share 2 | 0.2900 | 0.3600 | 0.5600 | 0.0900 | 0.0900 | 0.4400 |
| Capex 1 | 15 | 16.4 | 42.3 | 21.4 | 17.8 | 11.1 |
| Capex / Sales | 1.86% | 2.01% | 4.78% | 2.5% | 2.75% | 1.51% |
| Announcement Date | 4/24/19 | 4/26/20 | 4/28/21 | 4/29/22 | 4/26/23 | 4/26/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -39.88% | 387M | |
| +2.87% | 81.39B | |
| -9.51% | 31.85B | |
| -18.55% | 31.82B | |
| -3.42% | 16.59B | |
| +1.08% | 14.53B | |
| -15.69% | 11.59B | |
| +6.09% | 7.95B | |
| -18.88% | 6.84B | |
| -13.55% | 2.81B |
- Stock Market
- Equities
- 300225 Stock
- Financials Shanghai Kinlita Chemical Co., Ltd.